HomeInsightsResults

Ipca Laboratories Ltd Quarterly Result

Ipca Laboratories Ltd Quarterly Result

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Ipca Laboratories Ltd

NSE: IPCALAB

Net Profit

₹ 245.44

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Ipca Laboratories Ltd for the Sep '24 is ₹ 2381 crore as compare to the Jun '24 revenue of ₹ 2113 crore. This represent the growth of 12.678159%.
  • The ebitda of Ipca Laboratories Ltd for the Sep '24 is ₹ 467.74 crore as compare to the Jun '24 ebitda of ₹ 413.33 crore. This represent the growth of 13.163817%.
  • The net profit of Ipca Laboratories Ltd for the Sep '24 is ₹ 245.44 crore as compare to the Jun '24 net profit of ₹ 198.98 crore. This represent the growth of 23.349083%.

Results Analysis

Market Price of Ipca Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Ipca Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241590.55
21 Nov 20241573.2
19 Nov 20241573.1
18 Nov 20241566.85
14 Nov 20241536.95
13 Nov 20241508.15
12 Nov 20241557.15
11 Nov 20241531.5
08 Nov 20241556.65
07 Nov 20241557.55

Historical Revenue of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Ipca Laboratories Ltd

No data available

* All values are in crore

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories Ltd up for third straight session

Ipca Laboratories Ltd gained for a third straight session today. The stock is quoting at R...

Read more

19 Nov 202413:05

News

Board of Ipca Laboratories recommends Interim Dividend

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...

Read more

14 Nov 202415:29

News

Ipca Labs rises as Q2 PAT climbs 58% YoY to Rs 229 cr

Profit before tax surged 53.01% to Rs 344.83 crore in the September 2024 quarter from Rs 2...

Read more

14 Nov 202414:54

News

Ipca Laboratories schedules board meeting

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

25 Oct 202411:15

News

Board of Ipca Laboratories approves consolidation of USA generic formulations biz

The Board of Ipca Laboratories at its meeting held on 30 September 2024 has approved enter...

Read more

30 Sep 202418:44

News

Ipca Laboratories Ltd soars 1.97%, up for third straight session

Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs ...

Read more

25 Sep 202413:05

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

Aug 2023

Transcript

Apr 2023

Transcript

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Mar 2021

Transcript

Nov 2020

Transcript

Aug 2020

Transcript

June 2020

Transcript

Feb 2020

Transcript

FAQ's For Ipca Laboratories Ltd Quarterly Result

What is the EPS of Ipca Laboratories Ltd stock?

The Earnings Per Share (EPS) of Ipca Laboratories Ltd is 26.47. An EPS is the amount of net income attributed to each share of a common stock.

How is Ipca Laboratories Ltd EPS calculated?

The EPS of Ipca Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ipca Laboratories Ltd report its EPS?

Ipca Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ipca Laboratories Ltd EPS?

Factors that influence the EPS of Ipca Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ipca Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Ipca Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*